💊 दवाएँ A-Z 🧬 लक्ष्य 🛠 उपकरण 📚 मार्गदर्शिकाएँ
सभी दवाएँ दवा वर्ग चिकित्सीय क्षेत्र दुष्प्रभाव
मार्गदर्शिकाएँ शब्दकोश समयरेखा
तुलनाएँ दवाओं की यात्राएँ दवा परिवार
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Mesna

CHEMBL975 Phase 4 अनुमोदित Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
164.2 g/mol
LogP
—
Phase
4

A protective agent given alongside certain chemotherapy drugs (such as ifosfamide and cyclophosphamide) to prevent bladder damage (hemorrhagic cystitis) caused by toxic metabolites. It is usually administered intravenously in a hospital setting.

आणविक भार

164.1800 g/mol

TPSA

66.60 Ų

चिकित्सीय क्षेत्र

HIV/एड्स अग्नाशय कैंसर उच्च रक्तचाप ओवेरियन कैंसर कोलोरेक्टल कैंसर क्षय रोग (ट्यूबरकुलोसिस) थायरॉइड कैंसर नॉन-स्मॉल सेल लंग कैंसर प्रोस्टेट कैंसर मल्टीपल स्क्लेरोसिस मूत्राशय कैंसर मेलानोमा मोटापा लिम्फोमा ल्यूकेमिया सिस्टेमिक ल्यूपस एरिथेमेटोसस स्तन कैंसर हृदय विफलता

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
O=S(=O)([O-])CCS.[Na+]

                

                

                
                

                    
InChI

                    
InChI=1S/C2H6O3S2.Na/c3-7(4,5)2-1-6;/h6H,1-2H2,(H,3,4,5);/q;+1/p-1

                

                

                

                    
                    

                        
Molecular Formula

                        
C2H5NaO3S2

                    

                    
                    

                        
HBD / HBA

                        
1 / 4

                    

                    
                    

                        
घूर्णनीय बंधन

                        
2

                    

                    
                    
                    

                        
भारी परमाणु

                        
8

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
अक्सर पूछे जाने वाले प्रश्न

                

                    
                    

                        
                        

                            
A protective agent given alongside certain chemotherapy drugs (such as ifosfamide and cyclophosphamide) to prevent bladder damage (hemorrhagic cystitis) caused by toxic metabolites. It is usually administered intravenously in a hospital setting.

                        

                    

                    

                    

                    

                    

                    

                        
                        

                            
Yes, Mesna is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL975.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 23662354.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.




        


        
        
    


    



    
चिकित्सा अस्वीकरण

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.